News Ticker

[ December 9, 2023 ] New Data Reinforce the Benefit of Early Preventative Treatment With Genentech’s Hemlibra (emicizumab-kxwh) for Babies With Severe hemophilia A News
[ December 9, 2023 ] AbbVie’s $8.7B neuro gambit; Landmark sickle cell approvals; Roche buys a GLP-1 company; Endpoints 100 biotech survey; and more News
[ December 9, 2023 ] Research Scientist II, Assay Development – Exact Sciences Corporation – Redwood City, CA San Francisco Biotech Jobs
[ December 9, 2023 ] Chemist – Katalyst Healthcares & Life Sciences – Belmont, CA San Francisco Biotech Jobs
[ December 9, 2023 ] Associate Director/Director, Biostatistics – FibroGen, Inc. – San Francisco, CA San Francisco Biotech Jobs

How an East Bay biotech is engineering bacteria to defeat cancer

October 18, 2023 San Francisco Biotechnology Network News News, Syndication Comments Off

Investors in the six-year-old company include Boehringer Ingelheim and Illumina Ventures.
Click here to view original post

Copyright © 2023 Biotech Networks, LLC